Clinical and epidemiological issues in mammographic density

[1]  L. Kolonel,et al.  Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. , 2011, Cancer epidemiology.

[2]  Bernard Rosner,et al.  Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. , 2011, Journal of the National Cancer Institute.

[3]  N. Boyd,et al.  Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women , 2011, International journal of cancer.

[4]  S. Duffy,et al.  Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. , 2011, Journal of the National Cancer Institute.

[5]  Enzo Galligioni,et al.  Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. , 2011, European journal of cancer.

[6]  M. Yaffe,et al.  Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Duffy,et al.  Mammographic density and its interaction with other breast cancer risk factors in an Asian population , 2011, British Journal of Cancer.

[8]  Peter Kraft,et al.  Common variants in ZNF365 are associated with both mammographic density and breast cancer risk , 2011, Nature Genetics.

[9]  M. Yaffe,et al.  A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women , 2011, Breast Cancer Research and Treatment.

[10]  Harry J de Koning,et al.  BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Stephen W Duffy,et al.  Using mammographic density to predict breast cancer risk: dense area or percentage dense area , 2010, Breast Cancer Research.

[12]  V Shane Pankratz,et al.  Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Hartge,et al.  Effect of changing breast cancer incidence rates on the calibration of the Gail model. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Douglas Easton,et al.  Mammographic Density, Estrogen Receptor Status and Other Breast Cancer Tumor Characteristics , 2010, The breast journal.

[15]  L. Tabár,et al.  Effect of Baseline Breast Density on Breast Cancer Incidence, Stage, Mortality, and Screening Parameters: 25-Year Follow-up of a Swedish Mammographic Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[16]  D. English,et al.  Common genetic variants associated with breast cancer and mammographic density measures that predict disease. , 2010, Cancer research.

[17]  S. Duffy.  Epidemiology of female breast cancer , 2010 .

[18]  Norman F. Boyd,et al.  Screen-Film Mammographic Density and Breast Cancer Risk: A Comparison of the Volumetric Standard Mammogram Form and the Interactive Threshold Measurement Methods , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[19]  M. Yaffe,et al.  A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women , 2010, Breast Cancer Research and Treatment.

[20]  S. Cummings,et al.  Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. , 2009, Medical physics.

[21]  K. Kelly,et al.  Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts , 2009, European Radiology.

[22]  J. Cuzick,et al.  American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  V. McCormack,et al.  Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women , 2009, Breast Cancer Research.

[24]  Norman Boyd,et al.  Mammographic Density and Breast Cancer Risk: Evaluation of a Novel Method of Measuring Breast Tissue Volumes , 2009, Cancer Epidemiology Biomarkers & Prevention.

[25]  L. Bernstein,et al.  Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.

[26]  N. Schork,et al.  The Relative Importance of Genetics and Environment on Mammographic Density , 2009, Cancer Epidemiology Biomarkers & Prevention.

[27]  R. Vierkant,et al.  Assessment of the accuracy of the Gail model in women with atypical hyperplasia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Michael J. Carston,et al.  An Automated Approach for Estimation of Breast Density , 2008, Cancer Epidemiology Biomarkers & Prevention.

[29]  T. Sellers,et al.  Can genes for mammographic density inform cancer aetiology? , 2008, Nature Reviews Cancer.

[30]  R Janka,et al.  Automated breast ultrasound: lesion detection and BI-RADS classification--a pilot study. , 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[31]  Mary Wilson,et al.  Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view , 2008, Breast Cancer Research.

[32]  Sheila Prindiville,et al.  Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[33]  M. Yaffe.  Mammographic density. Measurement of mammographic density , 2008, Breast Cancer Research.

[34]  C. Streuli,et al.  Inhibitor of apoptosis proteins as a therapeutic target in breast cancer , 2008, Breast Cancer Research.

[35]  N. Karssemeijer,et al.  Differential impact of conventional and low‐dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method , 2008, BJOG : an international journal of obstetrics and gynaecology.

[36]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[37]  M. Yaffe,et al.  Is Mammography Adequate for Screening Women with Inherited BRCA Mutations and Low Breast Density? , 2008, Cancer Epidemiology Biomarkers & Prevention.

[38]  F. Schmidt.  Meta-Analysis , 2008 .

[39]  R. Warren,et al.  Breast cancer risk factors and a novel measure of volumetric breast density: cross-sectional study , 2007, British Journal of Cancer.

[40]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[41]  Helen Warren-Forward,et al.  Reproducibility of visual assessment on mammographic density , 2008, Breast Cancer Research and Treatment.

[42]  T. Sellers,et al.  Mammographic density, breast cancer risk and risk prediction , 2007, Breast Cancer Research.

[43]  R. Vierkant,et al.  Stratification of breast cancer risk in women with atypia: a Mayo cohort study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[45]  C. Vachon,et al.  Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. , 2007, Breast.

[46]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[47]  V. Shane Pankratz,et al.  Mammographic Breast Density as a General Marker of Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[48]  Graham A Colditz,et al.  Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. , 2006, Journal of the National Cancer Institute.

[49]  Anna Chiarelli,et al.  Body Size, Mammographic Density, and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[50]  Karla Kerlikowske,et al.  Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.

[51]  Jinbo Chen,et al.  Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.

[52]  Susan M. Astley,et al.  A New Step-Wedge for the Volumetric Measurement of Mammographic Density , 2006, Digital Mammography / IWDM.

[53]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[54]  N. Boyd,et al.  Mammographic Density as a Surrogate Marker for the Effects of Hormone Therapy on Risk of Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[55]  Russell Davies,et al.  Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2006, Cancer research.

[56]  R. Birdwell,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2006 .

[57]  S. Cummings,et al.  Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population , 2005, Breast Cancer Research and Treatment.

[58]  G. Colditz,et al.  Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[59]  C. D'Orsi,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.

[60]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[61]  M. Pike,et al.  Greatly increased occurrence of breast cancers in areas of mammographically dense tissue , 2005, Breast Cancer Research.

[62]  Joan Leach,et al.  Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.

[63]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[64]  S. Cummings,et al.  Mammographic density and estrogen receptor status of breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[65]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[66]  B. Geller,et al.  A prospective study of breast cancer risk using routine mammographic breast density measurements. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[68]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[69]  C. Jacobi,et al.  Risk Estimation for Healthy Women from Breast Cancer Families , 2004, Cancer Epidemiology Biomarkers & Prevention.

[70]  Navin Parekh,et al.  Effects of mammographic density and benign breast disease on breast cancer risk (United States) , 2001, Cancer Causes & Control.

[71]  T. Sellers,et al.  Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) , 2000, Cancer Causes & Control.

[72]  J. Otten,et al.  Mammographic breast density and risk of breast cancer: Masking bias or causality? , 1998, European Journal of Epidemiology.

[73]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[74]  A Howell,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.

[75]  Dan Rico,et al.  A volumetric method for estimation of breast density on digitized screen-film mammograms. , 2003, Medical physics.

[76]  Beth A Reboussin,et al.  Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.

[77]  Theo van der Kwast,et al.  A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography , 2002, International journal of cancer.

[78]  Zhimin Huo,et al.  Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. , 2002, Radiology.

[79]  Celine M Vachon,et al.  Case-control study of increased mammographic breast density response to hormone replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[80]  N F Boyd,et al.  The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.

[81]  Norman Boyd,et al.  A longitudinal study of the effects of menopause on mammographic features. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[82]  David Tritchler,et al.  Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.

[83]  J. Kaufhold,et al.  A calibration approach to glandular tissue composition estimation in digital mammography. , 2002, Medical physics.

[84]  L. Liberman,et al.  Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.

[85]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[86]  M. Freedman,et al.  Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. , 2001, Journal of the National Cancer Institute.

[87]  S. Duffy,et al.  High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. , 2000, International journal of epidemiology.

[88]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[89]  P. Langenberg,et al.  Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. , 2000, AJR. American journal of roentgenology.

[90]  B. Weber,et al.  Assessing the risk of breast cancer. , 2000, The New England journal of medicine.

[91]  A. Miller,et al.  Mammographic densities and the prevalence and incidence of histological types of benign breast disease , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[92]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[93]  H. Choo,et al.  Mammography in Asian patients with BRCA1 mutations , 1999, The Lancet.

[94]  M. Berer.  Mammography in Asian patients with BRCA1 mutations , 1999, The Lancet.

[95]  H. Goodare,et al.  NHS breast screening programme , 1999, BMJ.

[96]  S. Duffy,et al.  Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme , 1998, Journal of medical screening.

[97]  N. Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[98]  N. Boyd,et al.  Analysis of mammographic density and breast cancer risk from digitized mammograms. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[99]  L. Brinton.  Hormone replacement therapy and risk for breast cancer. , 1997, Endocrinology and metabolism clinics of North America.

[100]  B. Weber,et al.  Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience. , 1997, AJR. American journal of roentgenology.

[101]  J. Pankow,et al.  Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. , 1997, Journal of the National Cancer Institute.

[102]  N. Boyd,et al.  Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. , 1997, Journal of the National Cancer Institute.

[103]  L. Tabár,et al.  The Tabár classification of mammographic parenchymal patterns. , 1997, European journal of radiology.

[104]  松原 友子.  Third International Workshop on Digital Mammography に参加して , 1996 .

[105]  G. Chetrite,et al.  Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. , 1996, The Journal of clinical endocrinology and metabolism.

[106]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[107]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[108]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[109]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[110]  N. Boyd,et al.  Case-control study of factors associated with failure to detect breast cancer by mammography. , 1992, Journal of the National Cancer Institute.

[111]  N. Boyd,et al.  The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. , 1992, Cancer detection and prevention.

[112]  J. Cuzick,et al.  Mammographic dysplasia as entry criterion for breast cancer prevention trials , 1991, The Lancet.

[113]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[114]  P. Taylor,et al.  A prospective study of the development of breast cancer in 16,692 women with benign breast disease. , 1988, American journal of epidemiology.

[115]  A. W. Asscher.  Oral contraceptives and breast cancer. , 1987, British Journal of Cancer.

[116]  J. Wolfe,et al.  Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. , 1987, AJR. American journal of roentgenology.

[117]  C C Bird,et al.  Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. , 1985, Journal of clinical pathology.

[118]  J. Wolfe.  Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.